Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumor Infiltrating Lymphocytes in Metastatic Melanoma
2007-000776-16Phase 2Completed
- Sponsor
- Masaryk University
- Start
- May 2007
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous tumor-infiltrating lymphocytes in melanoma, sponsored by Masaryk University. Primary endpoint: Toxicity of TIL preparation. Started May 2007; status: completed.
02
Drugs
autologous tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on 2007-000776-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000776-16.